D.E. Shaw & Co’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Buy |
+10,437
| New | +$136K | ﹤0.01% | 2864 |
|
|
2024
Q2 | – | Sell |
-10,355
| Closed | -$350K | – | 3179 |
|
|
2024
Q1 | $350K | Sell |
10,355
-63,440
| -86% | -$2.14M | ﹤0.01% | 2547 |
|
|
2023
Q4 | $2.33M | Buy |
73,795
+29,166
| +65% | +$920K | ﹤0.01% | 1664 |
|
|
2023
Q3 | $1.14M | Sell |
44,629
-57,458
| -56% | -$1.47M | ﹤0.01% | 1979 |
|
|
2023
Q2 | $2.93M | Buy |
+102,087
| New | +$2.93M | ﹤0.01% | 1541 |
|
|
2022
Q1 | – | Sell |
-128,363
| Closed | -$4.75M | – | 4234 |
|
|
2021
Q4 | $4.75M | Buy |
128,363
+32,597
| +34% | +$1.21M | ﹤0.01% | 1707 |
|
|
2021
Q3 | $4.58M | Sell |
95,766
-209,324
| -69% | -$10M | ﹤0.01% | 1523 |
|
|
2021
Q2 | $10.3M | Buy |
305,090
+225,152
| +282% | +$7.62M | 0.01% | 1036 |
|
|
2021
Q1 | $3.3M | Buy |
+79,938
| New | +$3.3M | ﹤0.01% | 1563 |
|
|
2020
Q3 | – | Sell |
-5,874
| Closed | -$275K | – | 2566 |
|
|
2020
Q2 | $275K | Buy |
+5,874
| New | +$275K | ﹤0.01% | 2359 |
|
|
2017
Q2 | – | Sell |
-19,745
| Closed | -$158K | – | 2400 |
|
|
2017
Q1 | $158K | Buy |
19,745
+11,993
| +155% | +$96K | ﹤0.01% | 2307 |
|
|
2016
Q4 | $114K | Buy |
7,752
+3,098
| +67% | +$45.6K | ﹤0.01% | 2397 |
|
|
2016
Q3 | $80K | Sell |
4,654
-13,519
| -74% | -$232K | ﹤0.01% | 2423 |
|
|
2016
Q2 | $571K | Buy |
18,173
+946
| +5% | +$29.7K | ﹤0.01% | 2013 |
|
|
2016
Q1 | $457K | Buy |
17,227
+2,931
| +21% | +$77.8K | ﹤0.01% | 2096 |
|
|
2015
Q4 | $628K | Buy |
14,296
+9,935
| +228% | +$436K | ﹤0.01% | 1966 |
|
|
2015
Q3 | $184K | Buy |
4,361
+2,710
| +164% | +$114K | ﹤0.01% | 2362 |
|
|
2015
Q2 | $76K | Sell |
1,651
-5,520
| -77% | -$254K | ﹤0.01% | 2555 |
|
|
2015
Q1 | $283K | Buy |
7,171
+1,150
| +19% | +$45.4K | ﹤0.01% | 2270 |
|
|
2014
Q4 | $157K | Buy |
+6,021
| New | +$157K | ﹤0.01% | 2364 |
|